Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 22
Filtrar
Más filtros










Intervalo de año de publicación
1.
Viruses ; 15(10)2023 10 13.
Artículo en Inglés | MEDLINE | ID: mdl-37896866

RESUMEN

African swine fever (ASF) is a lethal and highly contagious transboundary animal disease with the potential for rapid international spread. Currently, there is no ASF vaccine commercially available. All infected animals must be isolated and culled immediately upon the confirmation of the presence of the virus. Studies leading to the rational development of protective ASF vaccines are urgently needed. Here, we generated a safe and efficacious live-attenuated vaccine (LAV) VNUA-ASFV-LAVL2 by serially passaging a field isolate (VNUA-ASFV-05L1, genotype II) in porcine alveolar macrophages (PAMs, 65 passages) and an immortalized porcine alveolar macrophage cell line (3D4/21, 55 passages). VNUA-ASFV-LAVL2 can efficiently replicate in both PAMs and 3D4/21 cells. It provides 100% protection, even with the low dose of 102 HAD50, to the vaccinated pigs against the challenge of contemporary pandemic ASFV field isolate. Pigs vaccinated with this LAV in a dose range of 102 to 105 HAD50 remained clinically healthy during both the 28-day observation period of immunization and the 28-day observation period of challenge. VNUA-ASFV-LAVL2 was eliminated from blood by 28 days post-inoculation (DPI), and from feces or oral fluids by 17 DPI. Although the vaccine strain in serum remained a safe and attenuated phenotype after five passages in swine, a reversion-to-virulence study using blood or tissue homogenates at peak viremia will be conducted in the future. ASFV-specific IgG antibodies and significant cellular immunity were detected in vaccinated pigs before the ASFV challenge. These results indicate that the VNUA-ASFV-LAVL2 strain is a safe and efficacious LAV against the genotype II ASFV strain responsible for current ASF outbreaks in Asia.


Asunto(s)
Virus de la Fiebre Porcina Africana , Fiebre Porcina Africana , Vacunas Virales , Porcinos , Animales , Vacunas Atenuadas , Pandemias
2.
Viruses ; 16(1)2023 Dec 19.
Artículo en Inglés | MEDLINE | ID: mdl-38275939

RESUMEN

The 2023 International African Swine Fever Workshop (IASFW) took place in Beijing, China, on 18-20 September 2023. It was jointly organized by the U.S.-China Center for Animal Health (USCCAH) at Kansas State University (KSU) and the Chinese Veterinary Drug Association (CVDA) and sponsored by the United States Department of Agriculture Foreign Agricultural Service (USDA-FAS), Harbin Veterinary Research Institute, and Zoetis Inc. The objective of this workshop was to provide a platform for ASF researchers around the world to unite and share their knowledge and expertise on ASF control and prevention. A total of 24 outstanding ASF research scientists and experts from 10 countries attended this meeting. The workshop included presentations on current ASF research, opportunities for scientific collaboration, and discussions of lessons and experiences learned from China/Asia, Africa, and Europe. This article summarizes the meeting highlights and presents some critical issues that need to be addressed for ASF control and prevention in the future.


Asunto(s)
Virus de la Fiebre Porcina Africana , Fiebre Porcina Africana , Porcinos , Animales , Humanos , Fiebre Porcina Africana/prevención & control , Fiebre Porcina Africana/epidemiología , Asia , China/epidemiología , África/epidemiología , Sus scrofa , Brotes de Enfermedades/veterinaria
3.
Res Vet Sci ; 153: 105-114, 2022 Dec 31.
Artículo en Inglés | MEDLINE | ID: mdl-36347064

RESUMEN

Canine distemper virus (CDV) is a pathogen causing fatal disease in a wide range of carnivores. Sequence analysis of CDV strains has been classified into several geographically-related lineages, and the evolution and emergence of these strains are not fully yet investigated. In this study, the complete H gene sequences of 15 CDV strains isolated on Vero DST cell culture from clinical samples of vaccinated domestic dogs in Vietnam were investigated. Fifteen CDV isolates belonging to Asia-1 CDV variants were predominant antigenic type circulated in Central and Northern Vietnam with notable differences regarding the region and some genetic variation, and the most closely related Asia-1 variants lineage reported in Vietnam, China, Taiwan, and Japan. All identified CDV isolates clustered into 2 novel clades Asia-1-C1 and Asia-1-C2. The major amino acid mutation variants of Vietnamese Asia-1 CDV strains were found at sites 51, 157, 159, 160, 171, 178, 186, 235, 245, 277, 288, 313, 324, 330, 337, 345, 358, 359, 365, 383, 446, 475, 517, 530, 584, 598 which include N-glycosylation sites and neutralizing epitope regions in H gene. The results of the virus neutralization titer (VNT) assay showed that the dogs vaccinated with commercial vaccines had significantly low VNT (4.89 and 12.8) against field CDV isolate strains (VNUA NA04, HN18, and NB05) isolated in northern and central Vietnam, respectively. These data may suggest the need for further research in CDV monitoring and development of preventative measures against CDV in Vietnam.

4.
J Reprod Infant Psychol ; : 1-12, 2022 Jul 19.
Artículo en Inglés | MEDLINE | ID: mdl-35852090

RESUMEN

OBJECTIVES: The present study aims to investigate whether each coping style used by Vietnamese people living with infertility diagnosis is associated with specific types of infertility-related stress (IRS). METHODS: In this cross-sectional design study, 997 patients with primary infertility diagnosis from three hospitals and two clinics in three regions of Vietnam completed questionnaire that consisted of Fertility Problem Inventory, the Copenhagen Multi-Centre Psychosocial Infertility and other questions. Four different linear regression analyses were performed on four coping styles. The five types of IRS and covariates were included in these models. FINDINGS: The results show that participants who experience all five types of IRS reported the dominant use of active-avoidance coping, while having four types of IRS, except for social concern, was associated with higher use of meaning-based coping. Utilising active-confronting coping was reported to be the outcome of experiencing increasing need for parenthood and decreasing rejection of child-free lifestyle. Choice of passive-avoidance coping was more common among those with increasing social concern and need for parenthood. Age and educational level impacted infertile people's choice of avoidance coping strategies. CONCLUSIONS: The results provide evidence to understand the direct impact of each type of IRS on infertile people's choice of coping styles to better support them during their individual and family therapy.

5.
Curr Issues Personal Psychol ; 10(3): 216-226, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-38013821

RESUMEN

BACKGROUND: Siblings play an important role in a child's life. However, many children often experience sibling bullying. This study investigates differences in sibling victimization by sex, age, a parent's absence from the home due to employment, or a child's privacy and the relationship between sibling victimization, peer victimization, and the child's well-being. PARTICIPANTS AND PROCEDURE: Participants were Vietnamese children participating in the third wave of the International Survey of Children's Well-Being. The study included 1537 children (811 boys and 726 girls) attending public schools, age 10-14 years (M = 11.29, SD = 1.15). RESULTS: The results show that over half of children with siblings in this study reported being victimized by a sibling. Younger children were bullied more often than older children. Children whose father worked away from home reported an increase in bullying behavior from their siblings. Children sharing a room with siblings reported being bullied more by siblings. CONCLUSIONS: The results indicated a positive correlation between sibling victimization and peer victimization and a negative relationship between being bullied and a child's subjective well-being.

6.
Vet World ; 14(7): 1853-1866, 2021 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-34475709

RESUMEN

BACKGROUND AND AIM: African swine fever (ASF) is currently the most prevalent disease in swine. The disease is spreading throughout primary swine-producing countries with heavy losses in population and revenue. To date, no successful vaccines or medications have been reported. This study aimed to design and develop a blend of natural essential oils and test its efficacy against the ASF virus (ASFV) in swine. MATERIALS AND METHODS: We attempted to develop a natural oil blend formulation (NOBF) and determine its efficacy against the ASFV. This study follows on from a previously published in vitro study that reported that the NOBF has anti-ASFV properties. A study was designed using 21 healthy piglets of triple-cross (Landrace + Yorkshire + Durok) crossbred pathogen-free pigs with an average weight of 15 kg. The study consisted of NOBF-incubated, NOBF, positive control, and negative control groups. The NOBF groups were administered NOBF (80 mL/ton mixed in drinking water) beginning 10 days before the challenge and continuing throughout the experiment. The positive and negative control pigs consumed regular drinking water. The pigs were challenged by a sublethal dose of pure isolate ASFV strain Vietnam National University of Agriculture-ASFV-L01/HN/04/19 inoculation with 103.5 HAD50/dose through the intramuscular route. There were sic pigs in each group, three pigs directly IM challenged, and three pigs were considered cohoused pigs. RESULTS: Both challenged (three) and cohoused (three) pigs in the positive control showed clinical signs of ASFV infection, as detected by real-time polymerase chain reaction (RT-PCR) in blood samples, oral swabs, and feces. There was 100% cumulative mortality, that is, both challenged and contact pigs died in the positive control group on day 20 of infection. No signs of infection or mortality were observed in the NOBF-incubated group. The challenged pigs in the NOBF-direct challenge group showed clinical signs and mortality, whereas no clinical signs or symptoms occurred in the cohoused pigs. The immunoglobulin G (IgG) level of the contact pigs was the highest in the treatment group and the lowest in the positive control group. The IgM level of the contact pigs in the treatment groups was the lowest, whereas that of the positive control was the highest. The RT-PCR test showed that the ASFV was deactivated in the NOBF-incubated group. The challenged and contact pigs of the positive control group had high Ct values. The challenged pigs of the NOBF group had high Ct values, whereas the contact pigs from the same group and those of the negative control were negative for the ASFV, determined by PCR, in all samples. The comparison of the challenged groups showed that the appearance of the virus was delayed by at least 2 days in the NOBF group compared to the positive control group. CONCLUSION: The results showed that NOBF can prevent the spread of the ASFV in a population. Moreover, NOBF can enhance the pig humoral immune system by enhancing IgG levels and reducing IgM levels. This study successfully demonstrated that NOBF is an anti-ASFV agent, which prevents horizontal transmission and enhances pig humoral immunity.

7.
J Vet Med Sci ; 83(11): 1653-1660, 2021 Oct 31.
Artículo en Inglés | MEDLINE | ID: mdl-34526423

RESUMEN

Investigation of the role of animals that have recovered and survived from African swine fever (ASF) in carrying the ASF virus is currently intense and ongoing. However, no clear definition of the carrier stage has been established. The aim of the present study was to establish criteria to elucidate a clear status of survival in naturally ASF-infected domestic pigs in Vietnam. Seroconversion from previous infection was confirmed by serological assay, and the absence of the viral genome in various organs was also assured by molecular analysis of a partial p72 gene. We recognized that histopathological evidence could benefit from further insights into the status and role of the surviving animals; therefore, we performed a histopathological study on four pigs from farms with a history of ASF outbreak. We found fibrotic changes in the reparative process as the main finding in all four pigs. Immunohistochemical detection of viral protein revealed an interesting result. Despite the negative result from viral genome detection, the p30 protein gave a positive signal in the tonsils, lung, and stomach. This raises the possibility of stress-induced viral reactivation in long-term survivors and the risk of further outbreaks from human handling of contaminated carcasses.


Asunto(s)
Fiebre Porcina Africana , Enfermedades de los Porcinos , Fiebre Porcina Africana/epidemiología , Animales , Antígenos Virales , Brotes de Enfermedades/veterinaria , Granjas , Genotipo , Filogenia , Sus scrofa , Porcinos , Enfermedades de los Porcinos/epidemiología , Vietnam/epidemiología
8.
Vet World ; 14(3): 794-802, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33935430

RESUMEN

BACKGROUND AND AIM: African swine fever is one of the severe pathogens of swine. It has a significant impact on production and economics. So far, there are no known remedies, such as vaccines or drugs, reported working successfully. In the present study, the natural oil blend formulation's (NOBF) efficacy was evaluated against ASFV in vitro using porcine alveolar macrophages (PAMs) cells of swine. MATERIALS AND METHODS: The capacity of NOBF against the ASFV was tested in vitro. The NOBF combines Eucalyptus globulus, Pinus sylvestris, and Lavandula latifolia. We used a 2-fold serial dilution to test the NOBF formulation dose, that is, 105 HAD50/mL, against purified lethal dose of African swine in primary PAMs cells of swine. The PAM cells survival, real-time polymerase chain reaction (PCR) test, and hemadsorption (HAD) observation were performed to check the NOBF efficacy against ASFV. RESULTS: The in vitro trial results demonstrated that NOBF up to dilution 13 or 0.000625 mL deactivates the lethal dose 105 HAD50 of ASFV. There was no HAD (Rosetta formation) up to dilution 12 or 0.00125 mL of NOBF. The Ct value obtained by running real-time PCR of the NOBF group at 96 h post-infection was the same as the initial value or lower (25), whereas the Ct value of positive controls increased several folds (17.84). CONCLUSION: The in vitro trial demonstrated that NOBF could deactivate the ASFV. The NOBF has the potential to act as anti-ASFV agent in the field. The next step is to conduct in vivo level trial to determine its efficacy.

9.
Microbiol Resour Announc ; 10(19)2021 May 13.
Artículo en Inglés | MEDLINE | ID: mdl-33986078

RESUMEN

This study reports the genome sequence of an isolated African swine fever (ASF) virus (VNUA-ASFV-05L1/HaNam) obtained at the fourth passage on pulmonary alveolar macrophages. The virus was isolated during a typical acute ASF outbreak in pigs in a northern province of Vietnam in 2020.

10.
Transbound Emerg Dis ; 68(4): 2039-2050, 2021 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32979250

RESUMEN

African swine fever (ASF) is emerging in Vietnam and poses a continuing severe threat to the swine industry. A histopathological study of clinical samples collected during the May to July 2019 outbreak of ASF was performed to determine the characteristic lesions. We analysed samples from eight ASFV-infected farms. Histopathological results revealed the characteristic lesions of the acute to the subacute clinical form of ASF. Immunohistochemical results showed ASFV viral antigen distribution in mononuclear cells/macrophage in various organs, hepatocytes and renal tubular epithelium. Molecular analysis of partial capsid protein 72 gene revealed that ASFV strain from the eight separate outbreaks belonged to genotype II.


Asunto(s)
Virus de la Fiebre Porcina Africana , Fiebre Porcina Africana , Enfermedades de los Porcinos , Fiebre Porcina Africana/epidemiología , Virus de la Fiebre Porcina Africana/genética , Animales , Antígenos Virales , Brotes de Enfermedades/veterinaria , Femenino , Genotipo , Porcinos , Vietnam/epidemiología
11.
J Vet Sci ; 21(2): e20, 2020 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-32233129

RESUMEN

Actinobacillus pleuropneumoniae (APP) causes a form of porcine pleuropneumonia that leads to significant economic losses in the swine industry worldwide. The apxIBD gene is responsible for the secretion of the ApxI and ApxII toxins and the pnp gene is responsible for the adaptation of bacteria to cold temperature and a virulence factor. The apxIBD and pnp genes were deleted successfully from APP serotype 1 and 5 by transconjugation and sucrose counter-selection. The APP1ΔapxIBDΔpnp and APP5ΔapxIBDΔpnp mutants lost hemolytic activity and could not secrete ApxI and ApxII toxins outside the bacteria because both mutants lost the ApxI- and ApxII-secreting proteins by deletion of the apxIBD gene. Besides, the growth of these mutants was defective at low temperatures resulting from the deletion of pnp. The APP1ΔapxIBDΔpnp and APP5ΔapxIBDΔpnp mutants were significantly attenuated compared with wild-type ones. However, mice vaccinated intraperitoneally with APP5ΔapxIBDΔpnp did not provide any protection when challenged with a 10-times 50% lethal dose of virulent homologous (APP5) and heterologous (APP1) bacterial strains, while mice vaccinated with APP1ΔapxIBDΔpnp offered 75% protection against a homologous challenge. The ΔapxIBDΔpnp mutants were significantly attenuated and gave different protection rate against homologous virulent wild-type APP challenging.


Asunto(s)
Actinobacillus pleuropneumoniae/fisiología , Eliminación de Gen , Genes Bacterianos , Infecciones por Actinobacillus/microbiología , Animales , Femenino , Ratones , Ratones Endogámicos BALB C , Serogrupo , Vacunación
12.
J Microbiol Biotechnol ; 30(7): 1037-1043, 2020 Jul 28.
Artículo en Inglés | MEDLINE | ID: mdl-32238774

RESUMEN

Actinobacillus pleuropneumoniae (APP) is a causative agent of porcine pleuropneumonia. Therefore, the development of an effective vaccine for APP is necessary. Here, we optimized the culture medium and conditions to enhance the production yields of Apx toxins in APP serotype 1, 2, and 5 cultures. The use of Mycoplasma Broth Base (PPLO) medium improved both the quantity and quality of the harvested Apx toxins compared with Columbia Broth medium. Calcium chloride (CaCl2) was first demonstrated as a stimulation factor for the production of Apx toxins in APP serotype 2 cultures. Cultivation of APP serotype 2 in PPLO medium supplemented with 10 µg/ml of nicotinamide adenine dinucleotide (NAD) and 20 mM CaCl2 yielded the highest levels of Apx toxins. These findings suggest that the optimization of the culture medium and conditions increases the concentration of Apx toxins in the supernatants of APP serotype 1, 2, and 5 cultures and may be applied for the development of vaccines against APP infection.


Asunto(s)
Actinobacillus pleuropneumoniae/metabolismo , Toxinas Bacterianas/biosíntesis , Medios de Cultivo/química , Infecciones por Actinobacillus/prevención & control , Actinobacillus pleuropneumoniae/crecimiento & desarrollo , Actinobacillus pleuropneumoniae/inmunología , Animales , Vacunas Bacterianas/inmunología , Cloruro de Calcio/metabolismo , Serogrupo , Porcinos , Enfermedades de los Porcinos/prevención & control
13.
Microb Pathog ; 95: 175-185, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27057678

RESUMEN

Brucella abortus RB51 is an attenuated vaccine strain that has been most frequently used for bovine brucellosis. Although it is known to provide good protection in cattle, it still has some drawbacks including resistance to rifampicin, residual virulence and pathogenicity in humans. Thus, there has been a continuous interest on new safe and effective bovine vaccine candidates. In the present study, we have constructed unmarked mutants by deleting singly cydD and cydC genes, which encode ATP-binding cassette transporter proteins, from the chromosome of the virulent Brucella abortus isolate from Korean cow (referred to as IVK15). Both IVK15ΔcydD and ΔcydC mutants showed increased sensitivity to metal ions, hydrogen peroxide and acidic pH, which are mimic to intracellular environment during host infection. Additionally, the mutants exhibited a significant growth defect in RAW264.7 cells and greatly attenuated in mice. Vaccination of mice with either IVK15ΔcydC or IVK15ΔcydD mutant could elicit an anti-Brucella specific immunoglobulin G (IgG) and IgG subclass responses as well as enhance the secretion of interferon-gamma, and provided better protection against challenge with B. abortus strain 2308 than with the commercial B. abortus strain RB51 vaccine. Collectively, these results suggest that both IVK15ΔcydC and IVK15ΔcydD mutants could be an attenuated vaccine candidate against B. abortus.


Asunto(s)
Transportadoras de Casetes de Unión a ATP/deficiencia , Vacunas Bacterianas/inmunología , Brucella abortus/inmunología , Brucella abortus/patogenicidad , Brucelosis Bovina/prevención & control , Factores de Virulencia/deficiencia , Animales , Anticuerpos Antibacterianos/sangre , Carga Bacteriana , Vacunas Bacterianas/administración & dosificación , Vacunas Bacterianas/genética , Brucella abortus/genética , Brucella abortus/aislamiento & purificación , Brucelosis Bovina/inmunología , Bovinos , Modelos Animales de Enfermedad , Eliminación de Gen , Inmunoglobulina G/sangre , Interferón gamma/metabolismo , Leucocitos Mononucleares/inmunología , Macrófagos/inmunología , Macrófagos/microbiología , Ratones , Ratones Endogámicos BALB C , Células RAW 264.7 , Bazo/microbiología , Bazo/patología , Vacunas Atenuadas/administración & dosificación , Vacunas Atenuadas/genética , Vacunas Atenuadas/inmunología , Virulencia
14.
Vaccine ; 34(2): 237-244, 2016 Jan 04.
Artículo en Inglés | MEDLINE | ID: mdl-26616550

RESUMEN

We constructed double deletion (ΔcydCΔcydD and ΔcydCΔpurD) mutants from virulent Brucella abortus biovar 1 field isolate (BA15) by deleting the genes encoding an ATP-binding cassette-type transporter (cydC and cydD genes) and a phosphoribosylamine-glycine ligase (purD). Both BA15ΔcydCΔcydD and BA15ΔcydCΔpurD double-mutants exhibited significant attenuation of virulence when assayed in murine macrophages or in BALB/c mice. Both double-mutants were readily cleared from spleens by 4 weeks post-inoculation even when inoculated at the dose of 10(8) CFU per mouse. Moreover, the inoculated mice showed no splenomegaly, which indicates that the mutants are highly attenuated. Importantly, the attenuation of in vitro and in vivo growth did not impair the ability of these mutants to confer long-term protective immunity in mice against challenge with B. abortus strain 2308. Vaccination of mice with either mutant induced humoral and cell-mediated immune responses, and provided significantly better protection than commercial B. abortus strain RB51 vaccine. These results suggest that highly attenuated BA15ΔcydCΔcydD and BA15ΔcydCΔpurD mutants can be used effectively as potential live vaccine candidates against bovine brucellosis.


Asunto(s)
Vacuna contra la Brucelosis/inmunología , Brucella abortus/genética , Brucella abortus/inmunología , Brucelosis/prevención & control , Eliminación de Gen , Factores de Virulencia/genética , Animales , Carga Bacteriana , Vacuna contra la Brucelosis/genética , Brucella abortus/patogenicidad , Brucelosis/microbiología , Brucelosis/patología , Línea Celular , Modelos Animales de Enfermedad , Femenino , Inmunidad Celular , Inmunidad Humoral , Macrófagos/microbiología , Ratones Endogámicos BALB C , Bazo/microbiología , Bazo/patología , Vacunas Atenuadas/genética , Vacunas Atenuadas/inmunología
15.
Microbiology (Reading) ; 161(11): 2137-48, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26341622

RESUMEN

Brucella abortus attenuated strain RB51 vaccine (RB51) is widely used in prevention of bovine brucellosis. Although vaccination with this strain has been shown to be effective in conferring protection against bovine brucellosis, RB51 has several drawbacks, including residual virulence for animals and humans. Therefore, a safe and efficacious vaccine is needed to overcome these disadvantages. In this study, we constructed several gene deletion mutants (ΔcydC, ΔcydD and ΔpurD single mutants, and ΔcydCΔcydD and ΔcydCΔpurD double mutants) of RB51 with the aim of increasing the safety of the possible use of these mutants as vaccine candidates. The RB51ΔcydC, RB51ΔcydD, RB51ΔpurD, RB51ΔcydCΔcydD and RB51ΔcydCΔpurD mutants exhibited significant attenuation of virulence when assayed in murine macrophages in vitro or in BALB/c mice. A single intraperitoneal immunization with RB51ΔcydC, RB51ΔcydD, RB51ΔcydCΔcydD or RB51ΔcydCΔpurD mutants was rapidly cleared from mice within 3 weeks, whereas the RB51ΔpurD mutant and RB51 were detectable in spleens until 4 and 7 weeks, respectively. Vaccination with a single dose of RB51 mutants induced lower protective immunity in mice than did parental RB51. However, a booster dose of these mutants provided significant levels of protection in mice against challenge with either the virulent homologous B. abortus strain 2308 or the heterologous Brucella canis strain 26. In addition, these mutants were found to induce a mixed but T-helper-1-biased humoral and cellular immune response in immunized mice. These data suggest that immunization with a booster dose of attenuated RB51 mutants provides an attractive strategy to protect against either bovine or canine brucellosis.


Asunto(s)
Vacuna contra la Brucelosis/inmunología , Brucella abortus/inmunología , Brucella canis/inmunología , Brucelosis/prevención & control , Inmunización Secundaria/métodos , Animales , Vacuna contra la Brucelosis/administración & dosificación , Vacuna contra la Brucelosis/efectos adversos , Vacuna contra la Brucelosis/aislamiento & purificación , Brucella abortus/genética , Brucelosis/inmunología , Brucelosis/microbiología , Modelos Animales de Enfermedad , Eliminación de Gen , Inmunidad Celular , Inmunidad Humoral , Inyecciones Intraperitoneales , Macrófagos/inmunología , Macrófagos/microbiología , Ratones Endogámicos BALB C , Vacunas Atenuadas/administración & dosificación , Vacunas Atenuadas/efectos adversos , Vacunas Atenuadas/inmunología , Vacunas Atenuadas/aislamiento & purificación , Virulencia , Factores de Virulencia/genética
16.
J Microbiol Biotechnol ; 25(2): 288-95, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25418479

RESUMEN

Salmonella enterica serovar Enteritidis is the predominant agent causing salmonellosis in chickens and other domestic animals. In an attempt to identify antigenic S. Enteritidis outer membrane proteins (OMPs) that may be useful for subunit vaccine development, we established a proteomic map and database of antigenic S. Enteritidis OMPs. In total, 351 and 301 spots respectively from S. Enteritidis strain 270 and strain 350 were detected by twodimensional gel electrophoresis. Fifty-one antigen-reactive spots were detected by antisera on two-dimensional immunoblots and identified as 12 specific proteins by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. OmpA and DNA starvation/ stationary phase protection protein (Dps) were the most abundant proteins among the identified OMPs, comprising 22 and 12 protein species, respectively. Interestingly, we found that the Dps of S. Enteritidis is also antigenic. OmpW was also verified to have high antigenicity. These results show that OmpA, Dps, and possibly OmpW are antigenic proteins. This study provides new insights into our understanding of the immunogenic characteristics of S. Enteritidis OMPs.


Asunto(s)
Antígenos Bacterianos/aislamiento & purificación , Proteínas de la Membrana Bacteriana Externa/inmunología , Proteínas de la Membrana Bacteriana Externa/aislamiento & purificación , Proteómica , Salmonella enteritidis/química , Animales , Antígenos Bacterianos/inmunología , Proteínas de la Membrana Bacteriana Externa/genética , Electroforesis en Gel Bidimensional , Immunoblotting , Ratones , Ratones Endogámicos BALB C , Salmonella enteritidis/inmunología , Salmonella enteritidis/aislamiento & purificación , Salmonella enteritidis/patogenicidad , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción
17.
J Vet Sci ; 16(2): 187-94, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25549217

RESUMEN

Salmonella enterica Gallinarum (SG) causes fowl typhoid (FT), a septicemic disease in avian species. We constructed deletion mutants lacking the stress sigma factor RpoS, the nitric oxide (NO)-detoxifying flavohemoglobin Hmp, and the SsrA/SsrB regulator to confirm the functions of these factors in SG. All gene products were fully functional in wild-type (WT) SG whereas mutants harboring single mutations or a combination of rpoS, hmp, and ssrAB mutations showed hypersusceptibility to H2O2, loss of NO metabolism, and absence of Salmonella pathogenicity island (SPI)-2 expression, respectively. A triple-deletion mutant, SGΔ3 (SGΔrpoSΔhmpΔssrAB), was evaluated for attenuated virulence and protection efficacy in two-week-old Lohmann layer chickens. The SGΔ3 mutant did not cause any mortality after inoculation with either 1 × 10(6) or 1 × 10(8) colony-forming units (CFUs) of bacteria. Significantly lower numbers of salmonellae were recovered from the liver and spleen of chickens inoculated with the SGΔ3 mutant compared to chickens inoculated with WT SG. Vaccination with the SGΔ3 mutant conferred complete protection against challenge with virulent SG on the chickens comparable to the group vaccinated with a conventional vaccine strain, SG9R. Overall, these results indicate that SGΔ3 could be a promising candidate for a live Salmonella vaccine against FT.


Asunto(s)
Proteínas Bacterianas/genética , Pollos , Enfermedades de las Aves de Corral/inmunología , Salmonelosis Animal/inmunología , Vacunas contra la Salmonella/inmunología , Salmonella enterica/fisiología , Administración Oral , Animales , Proteínas Bacterianas/inmunología , Femenino , Enfermedades de las Aves de Corral/microbiología , Salmonelosis Animal/microbiología , Vacunas contra la Salmonella/administración & dosificación , Vacunas contra la Salmonella/genética , Salmonella enterica/inmunología , Vacunas Atenuadas/administración & dosificación , Vacunas Atenuadas/genética , Vacunas Atenuadas/inmunología , Virulencia
18.
Microb Pathog ; 79: 1-7, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25546140

RESUMEN

In the present study, transposon mutagenesis was used to further attenuate Brucella abortus RB51 vaccine strain. Two purD and purF mutants were constructed, characterized and evaluated for attenuation via intracellular survival in murine macrophage-like RAW264.7 and HeLa cells, and by clearance in BALB/c mice. The purD and purF mutants showed significantly decreased intracellular survival, and complementation of these mutants with intact copies of purD or purF genes of RB51 strain was able to restore these defects. In addition, the pur mutants presented significantly lowered persistence in mice. Immunization with purD and purF mutants protected mice against a challenge with the virulent B. abortus strain 544 at a level similar to that of the parent RB51. These data suggest that genes encoding the early stages of purine biosynthesis (purD and purF) are required for intracellular survival and virulence of B. abortus.


Asunto(s)
Brucella abortus/crecimiento & desarrollo , Brucelosis/microbiología , Células Epiteliales/microbiología , Macrófagos/microbiología , Mutación , Factores de Virulencia/metabolismo , Animales , Vías Biosintéticas/genética , Brucella abortus/genética , Brucella abortus/metabolismo , Brucelosis/patología , Línea Celular , Elementos Transponibles de ADN , Modelos Animales de Enfermedad , Prueba de Complementación Genética , Ratones Endogámicos BALB C , Mutagénesis Insercional , Purinas/biosíntesis , Virulencia , Factores de Virulencia/genética
19.
Clin Vaccine Immunol ; 21(11): 1573-80, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25253663

RESUMEN

Brucella abortus readily multiplies in professional or nonprofessional phagocytes in vitro and is highly virulent in mice. Isogenic mutants of B. abortus biovar 1 strain IVKB9007 lacking the ATP/GDP-binding protein motif A (P-loop) (named looP; designated here the IVKB9007 looP::Tn5 mutant) and the ATP-binding/permease protein (cydC; designated here the IVKB9007 cydC::Tn5 mutant) were identified and characterized by transposon mutagenesis using the mini-Tn5Km2 transposon. Both mutants were found to be virtually incapable of intracellular replication in both murine macrophages (RAW264.7) and the HeLa cell line, and their virulence was significantly impaired in BALB/c mice. Respective complementation of the IVKB9007 looP::Tn5 and IVKB9007 cydC::Tn5 mutants restored their ability to survive in vitro and in vivo to a level comparable with that of the wild type. These findings indicate that the cydC and looP genes play important roles in the virulence of B. abortus. In addition, intraperitoneal immunization of mice with a dose of the live IVKB9007 looP::Tn5 and IVKB9007 cydC::Tn5 mutants provided a high degree of protection against challenge with pathogenic B. abortus strain 544. Both mutants should be evaluated further as a live attenuated vaccine against bovine brucellosis for their ability to stimulate a protective immune response.


Asunto(s)
Transportadoras de Casetes de Unión a ATP/genética , Proteínas Bacterianas/genética , Vacuna contra la Brucelosis/inmunología , Brucella abortus/inmunología , Proteínas Portadoras/genética , Factores de Virulencia/genética , Transportadoras de Casetes de Unión a ATP/deficiencia , Animales , Vacuna contra la Brucelosis/administración & dosificación , Vacuna contra la Brucelosis/genética , Vacuna contra la Brucelosis/aislamiento & purificación , Brucella abortus/genética , Brucella abortus/crecimiento & desarrollo , Línea Celular , Elementos Transponibles de ADN , Células Epiteliales/microbiología , Femenino , Eliminación de Gen , Prueba de Complementación Genética , Humanos , Inyecciones Intraperitoneales , Macrófagos/microbiología , Ratones Endogámicos BALB C , Mutagénesis Insercional , Vacunación/métodos , Vacunas Atenuadas/administración & dosificación , Vacunas Atenuadas/genética , Vacunas Atenuadas/inmunología , Vacunas Atenuadas/aislamiento & purificación , Virulencia , Factores de Virulencia/deficiencia
20.
FEMS Microbiol Lett ; 352(2): 213-20, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24461070

RESUMEN

The surface adhesin P97 mediates the adherence of Mycoplasma hyopneumoniae to swine cilia. Two reiterated repeats R1 and R2 are located at the C-terminus of P97. The purpose of this study was to evaluate the immunogenicity of Montanide adjuvant IMS 1113 plus soluble subunit proteins rR1, rR1R2 and their chimeric forms coupled with B subunit of the heat-labile enterotoxin of Escherichia coli (LTB). Each recombinant protein in this study was capable of eliciting anti-R1 specific humoral antibodies (IgG), mucosal antibodies (IgG and IgA) and IFN-γ production. The chimeric protein rLTBR1R2 elicited the quickest humoral antibody response among the recombinant proteins. Serum and bronchoalveolar lavage analysis revealed that each recombinant protein was capable of inducing both Th1 and Th2 responses. Importantly, all of the proteins induced an anti-R1-specific Th2-biased response in both humoral and mucosal compartments, similar to the response observed in a natural infection or vaccination process. These observations indicate that rR1, rR1R2, rLTBR1 and rLTBR1R2 with IMS 1113 might represent a promising subunit vaccine strategy against porcine enzootic pneumonia in pigs.


Asunto(s)
Adhesinas Bacterianas/inmunología , Adyuvantes Inmunológicos/administración & dosificación , Vacunas Bacterianas/inmunología , Mycoplasma hyopneumoniae/inmunología , Adhesinas Bacterianas/genética , Animales , Anticuerpos Antibacterianos/sangre , Toxinas Bacterianas/administración & dosificación , Vacunas Bacterianas/administración & dosificación , Vacunas Bacterianas/genética , Líquido del Lavado Bronquioalveolar/inmunología , Enterotoxinas/administración & dosificación , Proteínas de Escherichia coli/administración & dosificación , Femenino , Inmunidad Mucosa , Inmunoglobulina A/análisis , Inmunoglobulina G/análisis , Interferón gamma/metabolismo , Ratones Endogámicos BALB C , Proteínas Recombinantes/genética , Proteínas Recombinantes/inmunología , Suero/inmunología , Porcinos , Células TH1/inmunología , Células Th2/inmunología , Vacunas Sintéticas/administración & dosificación , Vacunas Sintéticas/genética , Vacunas Sintéticas/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...